Back arrow

Accretion Pha.

CMP

71.95

-0.20 (-0.28%)

  • DRHP
₹101

Offer Price

₹ 29.75 Cr

Issue Size

₹ 1,21,200

Min Investment

1,200

Lot size

Time Line

  • 14
    May 2025
    Open
  • 16
    May 2025
    Close
  • 19
    May 2025
    Finalisation of Basis of Allotment
  • 20
    May 2025
    Initiation of Refunds
  • 20
    May 2025
    Transfer of Shares to Demat Account
  • 21
    May 2025
    Listing Date

Shares Offered

Number of Times Subscribed

Objects of the Offer

  • Improve global presence.

  • Leveraging our market skills and relationship.

  • Maintaining edge over competitors.

  • Customer Satisfaction.

Strengths

  • Experienced Promoters and Management Team.

  • Consistently supplying quality products to our valued customers in time.

  • Continually improving the quality standards by implementing process control and prevention techniques.

  • Long-standing relationship with clients and suppliers.

  • Quality standards.

Risks

  • A significant portion of its revenue is derived from exports, and any decline in export profitability may adversely impact its overall financial performance.

  • The Company operates in pharmaceutical sector, which is extensively regulated, any failures on the company part to comply with the existing and future statutory and/or regulatory requirements in the pharmaceutical sector could adversely affect its business, results of operations and financial condition.

  • Its manufacturing units are subject to periodic inspections and audits by regulatory authorities and clients. Its may be subject to regulatory action which may damage the company reputation leading to an adverse effect on its business, results of operations, financial condition and cash flows.

  • The company has a very limited operating history as a Company, which may make it difficult for investors to evaluate its historical performance or future prospects.

  • The company has only one Manufacturing Facility, continued operations of its manufacturing facility is critical to the company business and any disruption in the operation of its manufacturing facility may have a material adverse effect on the company business, results of operations and financial condition.

Company Promoters

Promoters Holding

Issue For IPO
26.86%
Pre Holding

100.00%

Post Holding

73.14%

Top Promoters Holding

Financials

All values in Cr

Mar-2024
Revenue 13.35 (-)
Gross Profit 2.22 (-)
Net Income 1.49 (-)
Assets 18.97 (-)
Liabilities 13.48 (-)

Peers

Company Name Revenue (Cr) Net Profit (Cr) Assets (Cr) Liabilities (Cr) ROE EPS BVPS Current Ratio Debt to Assets
Accretion Pharmaceuticals Ltd 13.35 1.49 18.97 13.48 38.54 0.00 13.73 2.72 0.71
Sakar Healthcare Ltd 153.35 11.67 388.66 388.66 4.44 5.63 120.61 3.00 0.26
Lincoln Pharmaceuticals Ltd 580.55 93.30 700.29 700.29 15.73 46.58 295.98 13.32 0.00
Sotac Pharmaceuticals Ltd 103.83 3.58 105.33 105.33 7.90 3.90 44.64 3.39 0.55

Book Running Managers

  • Jawa Capital Services Pvt Ltd

Registrar & Transfer Agent

KFin Techologies Ltd

Karvy Selenium Tow-B,
31&32 Financial Dist,
Nanakramguda - Hyderabad-500032
Phone : 91-40-67162222 Fax: 91-40-23001153/23420814

Company Contact Information

29 Xcelon Ind Park 1,
Vasna Chacharvadi Sanand,
Ahmedabad - 382213
Phone : +91 97148 82929 Email : care@accretionpharma.com http://www.accretionpharma.com

Offer Related Information

Initial public offer of upto 29,46,000 equity shares of face value of Rs. 10/- each (the equity shares) of Accretion Pharmaceuticals Limited (the company or accretion or the issuer) at an issue price of Rs. 101 per equity share for cash, aggregating up to Rs. 29.75 crores (public issue) out of which 1,47,600 equity shares of face value of Rs. 10 each, at an issue price of Rs. 101 per equity share for cash, aggregating Rs. 1.49 crores will be reserved for subscription by the market maker to the... More

Accretion Pha. FAQ's

The shares of Accretion Pha. were first listed on the stock exchanges on June 26, 2024.

The total issue size of the Accretion Pha. IPO was 1,10,00,000 shares, amounting to Rs. 132 crore. they

The minimum lot size for Accretion Pha. public issue was 125 shares.

The price band of the IPO of Accretion Pha. was Rs. 114 to Rs. 120 per equity share.

Accretion Pha. IPO is a public issue through which the company raised approximately Rs. 132 crore by issuing around 1.1 crore equity shares to the public. After a successful IPO, the company’s shares are currently listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE), where they are freely traded without restrictions.

Bigshare Services Private Limited is the registrar and share transfer agent of Accretion Pha. IPO.

Download Our App On: